Mckesson (MCK) Capital Expenditures Growth (1y) (2010 - 2026)
Mckesson (MCK) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -32.11% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 28.33% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 15.87% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -19.35% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 57.22% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 780.43% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -9.03% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.11% |
| Dec 31, 2025 | 162.07% |
| Sep 30, 2025 | -23.20% |
| Jun 30, 2025 | 27.87% |
| Mar 31, 2025 | 738.46% |
| Dec 31, 2024 | -132.22% |
| Sep 30, 2024 | 69.16% |
| Jun 30, 2024 | 32.61% |
| Mar 31, 2024 | -77.19% |
| Dec 31, 2023 | 295.65% |
| Sep 30, 2023 | -16.41% |
| Jun 30, 2023 | 58.62% |
| Mar 31, 2023 | 153.77% |
| Dec 31, 2022 | -128.75% |
| Sep 30, 2022 | 374.07% |
| Jun 30, 2022 | -56.06% |
| Mar 31, 2022 | -2.91% |
| Dec 31, 2021 | -20.79% |
| Sep 30, 2021 | -41.30% |
| Jun 30, 2021 | 46.67% |